PER percheron therapeutics limited
Add to My Watchlist 11.1% ! 1.0¢

News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial...

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    19/12/22
    10:20
    Post #: 65363435

    Dec 19 (Reuters) - Antisense Therapeutics Ltd (ANP) :

    • CLINICAL TRIAL APPLICATION SUBMITTED FOR ATL1102 PHASE IIB DMD TRIAL CONDUCT IN EUROPE
    • CTA APPROVALS ARE EXPECTED TO COME THROUGH IN A STAGGERED MANNER IN EARLY 2023
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS Win a $12k Portfolio | 7%-10.25% low risk rental yield from a proven asset
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS DroneShield's civilian counter-drone tech lands with a buzz
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
0.001(11.1%) 		Mkt cap ! $10.87M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $65.04K 6.509M

Buyers (Bids)

No. Vol. Price($)
10 7255339 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 885979 2
View Market Depth
Last trade - 15.51pm 13/08/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.